Consumer Price Index CPI in the United States increased to 323.98 points in August from 323.05 points in July of 2025. This dataset provides the latest reported value for - United States Consumer Price Index (CPI) - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.

Discover the surprising stability of new car prices in April's CPI report, as dealerships use inventory strategies to counteract tariff impacts.

Key information about Switzerland Consumer Price Index CPI growth

• Switzerland Consumer Price Index (CPI) growth was measured at -0.5 % YoY in Jan 2021, compared with a rate of -0.8 % in the previous month.
• Switzerland Consumer Price Index growth data is updated monthly, available from Jan 1922 to Jan 2021, with an averaged number of 1.4 % YoY.
• The data reached an all-time high of 17.7 % YoY in Aug 1941 and a record low of -21.5 % YoY in May 1922.

View monthly updates and historical trends for US Consumer Price Index: Eggs. from United States. Source: Bureau of Labor Statistics. Track economic data …

The Federal Reserve Bank of Cleveland provides daily “nowcasts” of inflation for two popular price indexes, the price index for personal consumption expenditures (PCE) and the Consumer Price Index (CPI). These nowcasts give a sense of where inflation is today. Released each business day.

The colorless and transparent polyimide (CPI) market is experiencing robust growth, driven by increasing demand across diverse sectors. While precise market size figures for 2025 are unavailable, considering a plausible CAGR of 15% (a conservative estimate given the growth in related advanced materials sectors) and a 2019 market size of approximately $200 million (this is an assumption for illustrative purposes; a more accurate number would be needed for a truly precise analysis), the 2025 market size would be estimated at approximately $500 million. This growth trajectory is projected to continue throughout the forecast period (2025-2033), with a sustained CAGR of around 12%. Key drivers include the expanding adoption of CPI in flexible displays, advanced electronics, and high-performance optical applications. The demand for lightweight, high-strength, and thermally stable materials is further fueling the market's expansion. Trends like miniaturization in electronics and the rise of foldable devices are creating significant opportunities for CPI manufacturers. However, the market also faces certain restraints. High production costs and the complex manufacturing process can limit widespread adoption. Moreover, the availability of alternative materials with comparable properties could pose a challenge. Nonetheless, ongoing research and development efforts focused on improving the cost-effectiveness and expanding the applications of CPI are expected to mitigate these challenges. The major players in this market, including Kolon, DuPont, Nexolve Materials, MGC, Kaneka, Sumitomo Chemical, SKC, and several Chinese manufacturers, are actively engaged in developing innovative CPI products and expanding their market presence. Geographical segmentation reveals strong growth in Asia-Pacific, driven by the booming electronics industry in regions like China and South Korea. North America and Europe also represent significant, albeit more mature, market segments.

The Cell Processing Isolator (CPI) market is experiencing steady growth, projected to reach a value of $123 million in 2025, with a compound annual growth rate (CAGR) of 3.8% from 2025 to 2033. This expansion is driven by several key factors. The increasing prevalence of cell and gene therapies, coupled with stringent regulatory requirements for aseptic processing and contamination control, are significantly boosting demand for CPIs. Advancements in isolator technology, such as improved automation and user-friendly interfaces, are making them more accessible and efficient for various applications within biopharmaceutical manufacturing. Furthermore, the growing focus on personalized medicine and the increasing investment in research and development for novel cell therapies are contributing to the overall market expansion. The market is segmented based on factors such as isolator type (e.g., rigid-wall, flexible), application (e.g., cell culture, aseptic processing), and end-user (e.g., pharmaceutical companies, research institutions). Key players like Esco Micro Pte, Shibuya, Airtech System, Zhejiang TAILIN Bioengineering, and Tianjin Becquerel & Sievert Technology are actively shaping the market landscape through innovation and expansion. The continued growth of the CPI market is expected to be supported by ongoing technological advancements, such as the integration of single-use technologies and improved monitoring systems. The increasing demand for efficient and reliable cell processing solutions in emerging markets will further propel market growth. However, factors such as high initial investment costs associated with CPI acquisition and the need for skilled personnel to operate these systems could pose certain challenges. Despite these restraints, the long-term outlook for the CPI market remains positive, driven by the continued expansion of the cell and gene therapy industry and the increasing adoption of CPIs across various applications. The market is anticipated to demonstrate sustained growth through 2033, with further market segmentation analysis revealing specific growth trajectories within various sub-sectors.

Boston Beer (SAM) shares gained 3% after the July CPI report showed cooling inflation, boosting optimism for food and beverage sector profitability.

The global Cell Processing Isolator (CPI) market, valued at $89 million in 2025, is projected to experience steady growth, driven by the increasing demand for advanced cell therapies and the rising prevalence of chronic diseases requiring cell-based treatments. This growth is further fueled by stringent regulatory requirements for aseptic processing, necessitating the adoption of CPIs to ensure product sterility and patient safety. Technological advancements in CPI design, such as improved automation and ease of use, are also contributing to market expansion. While the 3.9% CAGR suggests moderate growth, the market is expected to see accelerated expansion in the coming years due to the growing adoption of personalized medicine and the increasing investment in cell and gene therapy research and development. The competitive landscape is characterized by a mix of established players like Esco Micro Pte and Airtech Systems, and emerging companies like Zhejiang TAILIN Bioengineering, indicating a dynamic and evolving market. The market segmentation, while not explicitly provided, can be reasonably inferred to include isolators based on technology (e.g., hard-walled, flexible), application (e.g., aseptic processing, cell culture), and end-user (e.g., hospitals, research institutions, pharmaceutical companies). Geographic distribution likely mirrors global trends in healthcare infrastructure and investment in cell therapy, with North America and Europe holding significant market shares. Challenges include the high initial investment cost of CPIs and the need for specialized training for operation and maintenance, potentially hindering adoption in some regions. However, the long-term benefits in terms of product quality, safety, and regulatory compliance are expected to outweigh these challenges, supporting the continued growth of the CPI market.

Lamb Weston’s stock gained 3% after a favorable CPI report, though it remains down YTD. The company recently beat earnings but faces ongoing market volatility.

Inflation Nowcasting Monthly Year-Over-Year is a part of the Inflation Nowcasting indicator of the Federal Reserve Bank of Cleveland.